Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Monotherapy Versus Dual Therapy for Initial Treatment for Hypertension

NCT00994617 is registered in ClinicalTrials.gov with University of Cambridge as lead sponsor.

NCT NCT00994617
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00994617 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Monotherapy Versus Dual Therapy for Initial Treatment for Hypertension
Lead sponsor
University of Cambridge
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2010
Completion date
December 31, 2014
Enrollment
600 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

essential hypertension, hypertension, resistant to conventional therapy